Daniel Heinrichs

887 total citations
15 papers, 693 citations indexed

About

Daniel Heinrichs is a scholar working on Immunology, Epidemiology and Hepatology. According to data from OpenAlex, Daniel Heinrichs has authored 15 papers receiving a total of 693 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Immunology, 8 papers in Epidemiology and 7 papers in Hepatology. Recurrent topics in Daniel Heinrichs's work include Liver physiology and pathology (7 papers), Liver Disease Diagnosis and Treatment (7 papers) and Macrophage Migration Inhibitory Factor (6 papers). Daniel Heinrichs is often cited by papers focused on Liver physiology and pathology (7 papers), Liver Disease Diagnosis and Treatment (7 papers) and Macrophage Migration Inhibitory Factor (6 papers). Daniel Heinrichs collaborates with scholars based in Germany, United States and Switzerland. Daniel Heinrichs's co-authors include Christian Trautwein, Marie‐Luise Berres, Hermann E. Wasmuth, P Schmitz, Andreas Nellen, Christian Weber, Ralf Weiskirchen, Mirko Moreno Zaldivar, Jürgen Bernhagen and Hacer Sahin and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and PLoS ONE.

In The Last Decade

Daniel Heinrichs

14 papers receiving 686 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel Heinrichs Germany 12 332 295 245 125 74 15 693
Mirko Moreno Zaldivar Germany 9 427 1.3× 434 1.5× 191 0.8× 151 1.2× 141 1.9× 10 801
Kunimaro Furuta Japan 17 405 1.2× 298 1.0× 90 0.4× 293 2.3× 55 0.7× 32 776
Po–Sung Chu Japan 15 442 1.3× 343 1.2× 242 1.0× 154 1.2× 75 1.0× 42 825
Eva Efsen Italy 10 504 1.5× 518 1.8× 241 1.0× 278 2.2× 264 3.6× 12 1.1k
H Senoh Japan 6 153 0.5× 118 0.4× 350 1.4× 142 1.1× 124 1.7× 14 771
Fabrizio Scatena Italy 17 154 0.5× 107 0.4× 162 0.7× 122 1.0× 80 1.1× 35 632
Chloé Abels Belgium 6 229 0.7× 139 0.5× 569 2.3× 262 2.1× 137 1.9× 6 910
Hannah K. Drescher United States 14 281 0.8× 123 0.4× 85 0.3× 167 1.3× 33 0.4× 25 511
Dianyuan Zhao China 10 192 0.6× 187 0.6× 398 1.6× 221 1.8× 126 1.7× 20 776
Cynthia L. Bone‐Larson United States 9 118 0.4× 221 0.7× 195 0.8× 112 0.9× 158 2.1× 10 617

Countries citing papers authored by Daniel Heinrichs

Since Specialization
Citations

This map shows the geographic impact of Daniel Heinrichs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Heinrichs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Heinrichs more than expected).

Fields of papers citing papers by Daniel Heinrichs

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Heinrichs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Heinrichs. The network helps show where Daniel Heinrichs may publish in the future.

Co-authorship network of co-authors of Daniel Heinrichs

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Heinrichs. A scholar is included among the top collaborators of Daniel Heinrichs based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Heinrichs. Daniel Heinrichs is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Brandt, Elisa, Alexandra C.A. Heinzmann, Petra Fischer, et al.. (2022). Extracellular Vesicles from Steatotic Hepatocytes Provoke Pro-Fibrotic Responses in Cultured Stellate Cells. Biomolecules. 12(5). 698–698. 7 indexed citations
2.
Wirtz, Theresa H., Petra Fischer, Daniel Heinrichs, et al.. (2021). Macrophage migration inhibitory factor exerts pro‐proliferative and anti‐apoptotic effects via CD74 in murine hepatocellular carcinoma. British Journal of Pharmacology. 178(22). 4452–4467. 35 indexed citations
3.
Heinrichs, Daniel, Elisa Brandt, Petra Fischer, et al.. (2021). Unexpected Pro-Fibrotic Effect of MIF in Non-Alcoholic Steatohepatitis Is Linked to a Shift in NKT Cell Populations. Cells. 10(2). 252–252. 13 indexed citations
4.
Wirtz, Theresa H., Petra Fischer, Elisa Brandt, et al.. (2019). Genetic Variants in the Promoter Region of the Macrophage Migration Inhibitory Factor are Associated with the Severity of Hepatitis C Virus-Induced Liver Fibrosis. International Journal of Molecular Sciences. 20(15). 3753–3753. 4 indexed citations
5.
Kim, Bong‐Sung, Pathricia V. Tilstam, Corinna Schmitz, et al.. (2017). Characterization of adipose tissue macrophages and adipose-derived stem cells in critical wounds. PeerJ. 5. e2824–e2824. 12 indexed citations
6.
Drescher, Hannah K., Daniela C. Kroy, Daniel Heinrichs, et al.. (2015). The Anti-Microbial Peptide LL-37/CRAMP Is Elevated in Patients with Liver Diseases and Acts as a Protective Factor during Mouse Liver Injury. Digestion. 91(4). 307–317. 13 indexed citations
7.
Heinrichs, Daniel, Marie‐Luise Berres, Andreas Nellen, et al.. (2014). Protective role of macrophage migration inhibitory factor in nonalcoholic steatohepatitis. The FASEB Journal. 28(12). 5136–5147. 50 indexed citations
8.
Heinrichs, Daniel, Marie‐Luise Berres, Andreas Nellen, et al.. (2013). The Chemokine CCL3 Promotes Experimental Liver Fibrosis in Mice. PLoS ONE. 8(6). e66106–e66106. 57 indexed citations
9.
Heinrichs, Daniel & Jürgen Bernhagen. (2013). Die Bedeutung des Zytokins MIF bei der Entwicklung einer chronischen Leberschädigung. RWTH Publications (RWTH Aachen).
10.
Hammerich, Linda, Marie‐Luise Berres, Daniel Heinrichs, et al.. (2013). Met-CCL5 modifies monocyte subpopulations during liver fibrosis regression.. PubMed. 6(4). 678–85. 17 indexed citations
11.
Zaldivar, Mirko Moreno, Marie‐Luise Berres, Hacer Sahin, et al.. (2012). The chemokine receptor CXCR3 limits injury after acute toxic liver damage. Laboratory Investigation. 92(5). 724–734. 16 indexed citations
12.
Sahin, Hacer, Erawan Borkham‐Kamphorst, Christoph Kuppe, et al.. (2012). Chemokine Cxcl9 attenuates liver fibrosis-associated angiogenesis in mice. Hepatology. 55(5). 1610–1619. 112 indexed citations
13.
Nellen, Andreas, Daniel Heinrichs, Marie‐Luise Berres, et al.. (2012). Interference with Oligomerization and Glycosaminoglycan Binding of the Chemokine CCL5 Improves Experimental Liver Injury. PLoS ONE. 7(5). e36614–e36614. 15 indexed citations
14.
Heinrichs, Daniel, Marie‐Luise Berres, Andreas Nellen, et al.. (2011). Macrophage migration inhibitory factor (MIF) exerts antifibrotic effects in experimental liver fibrosis via CD74. Proceedings of the National Academy of Sciences. 108(42). 17444–17449. 123 indexed citations
15.
Berres, Marie‐Luise, Rory R. Koenen, Mirko Moreno Zaldivar, et al.. (2010). Antagonism of the chemokine Ccl5 ameliorates experimental liver fibrosis in mice. Journal of Clinical Investigation. 120(11). 4129–4140. 219 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026